[Federal Register Volume 78, Number 164 (Friday, August 23, 2013)]
[Notices]
[Page 52579]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-20622]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[Docket No. 50-608; NRC-2013-0053]


SHINE Medical Technologies, Inc.

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of receipt and availability.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) staff 
acknowledges receipt of the second and final part of a two-part 
application for a construction permit, submitted by SHINE Medical 
Technologies, Inc. (SHINE).

ADDRESSES: Please refer to Docket ID NRC-2013-0053 when contacting the 
NRC about the availability of information regarding this document. You 
may access publicly-available information related to this action by the 
following methods:
     Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2013-0053. Address 
questions about NRC dockets to Carol Gallagher; telephone: 301-287-
3422; email: [email protected]. For technical questions, contact 
the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section 
of this document.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may access publicly available documents online in the NRC 
Library at http://www.nrc.gov/reading-rm/adams.html. To begin the 
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's 
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to [email protected]. The ADAMS accession number 
for each document referenced in this document (if that document is 
available in ADAMS) is provided the first time that the document is 
referenced. The application is available in ADAMS under Accession No. 
ML13172A324.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.

FOR FURTHER INFORMATION CONTACT: Steven Lynch, Office of Nuclear 
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC, 
20555-0001; telephone: 301-415-1524; email: [email protected].

SUPPLEMENTARY INFORMATION: By letter dated May 31, 2013, SHINE filed 
with the NRC, pursuant to Section 103 of the Atomic Energy Act and part 
50 of Title 10 of the Code of Federal Regulations (10 CFR), the second 
and final portion of a two-part application for a construction permit 
for a medical radioisotope production facility in Janesville, Wisconsin 
(SMT-2013-023, ADAMS Accession No. ML13172A361).
    An exemption from certain requirements of 10 CFR 2.101(a)(5), 
granted by the Commission on March 20, 2013 (ADAMS Accession No. 
ML13072B195), in response to a letter from SHINE dated February 18, 
2013 (ADAMS Accession No. ML13051A007), allowed SHINE to submit its 
construction permit application in two parts. Specifically, the 
exemption allowed SHINE to submit a portion of its application for a 
construction permit up to six months prior to the remainder of the 
application regardless of whether or not an environmental impact 
statement or a supplement to an environmental impact statement is 
prepared during the review of its application. SHINE submitted part one 
of its construction permit application by letter dated March 26, 2013 
(ADAMS Accession No. ML13088A192). A notice of receipt and availability 
of part one of the construction permit application was previously 
published in the Federal Register on May 20, 2013 (78 FR 29390). The 
first part of SHINE's construction permit application contained the 
following information:

 The description and safety assessment of the site required by 
10 CFR 50.34(a)(1)
 The environmental report required by 10 CFR 50.30(f)
 The filing fee information required by 10 CFR 50.30(e) and 10 
CFR 170.21
 The general information required by 10 CFR 50.33
 The agreement limiting access to classified information 
required by 10 CFR 50.37

    The NRC staff published in the Federal Register on July 1, 2013 (78 
FR 39342), its determination that part one of SHINE's construction 
permit application is acceptable for docketing.
    Part two of SHINE's application for a construction permit contains 
the remainder of the preliminary safety analysis report, as required by 
10 CFR 50.34(a).
    Subsequent Federal Register notices will address the acceptability 
of this second portion of the tendered construction permit application 
for docketing and detail provisions for public participation in the 
construction permit application review process.

    Dated at Rockville, Maryland, this 16th day of August, 2013.

    For the Nuclear Regulatory Commission.
Alexander Adams, Jr.,
Chief, Research and Test Reactors Licensing Branch, Division of Policy 
and Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2013-20622 Filed 8-22-13; 8:45 am]
BILLING CODE 7590-01-P